3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
29
Terminated
12
Active not recruiting
9
Recruiting
8
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
4
Lymphoid
4
CNS
3
Sarcoma
1
Other solid neoplasm
1
Myeloid
1
Dermatologic
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Interventions
Cyclophosphamide
14
fludarabine phosphate
9
Peripheral Blood Stem Cell Transplantation
9
fludarabine
8
Cytarabine
8
Busulfan
8
Azacitidine
8
Whole-Body Irradiation
7
Methotrexate
7
Cyclosporine
6
Tacrolimus
5
Filgrastim
5
Decitabine
5
nilotinib
4
Mycophenolic Acid
4
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Dasatinib
3
Biopsy
3
AP 1903 reagent
3
venetoclax
2
sabatolimab
2
ruxolitinib
2
merphos
2
magrolimab
2
ivosidenib
2
decitabine and cedazuridine drug combination
2
Stem Cell Transplantation
2
Specimen Handling
2
Sirolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Thiotepa
×
Myeloid
×
Clear all
NCT04282174
2022-09-27
2019-KOE-001
Baptist Health South Florida
Phase 2
Withdrawn